Treatmybrand


a Kainjoo SA Venture
Ch. du Vernay 14a
1196 Gland
+41.21.561.34.96
info@treatmybrand.com

Support


Monday to Friday
8AM to 8PM
support@treatmybrand.com
Back

Merck and Isomorphic Labs agree research deal on new cancer drugs

Merck and Isomorphic Labs said they are entering into a research collaboration to discover small molecule candidates in oncology, according to STAT. No financial terms or specific targets were disclosed in the announcement.

This move signals another large pharma company seeking external innovation in cancer drug discovery. For pharma and biotech leaders, this may mean more competition for partnerships and a shift in how oncology pipelines are built. Further information on the collaboration’s scope will be important for assessing its impact.

Stat
Stat